SAM
CNMD icon

Silvercrest Asset Management’s CONMED CNMD Stock Holding History

Silvercrest Asset Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.4M Sell
441,361
-207,216
-32% -$7.46M 0.09% 277
2026
Q1 		$22.9M Sell
648,577
-218,198
-25% -$8.88M 0.17% 166
2025
Q4 		$35.2M Sell
866,775
-206,969
-19% -$9M 0.24% 115
2025
Q3 		$50.5M Buy
1,073,744
+221,799
+26% +$11.5M 0.33% 87
2025
Q2 		$44.4M Sell
851,945
-183,659
-18% -$10.1M 0.3% 101
2025
Q1 		$62.5M Buy
1,035,604
+34,885
+3% +$2.25M 0.45% 64
2024
Q4 		$68.5M Buy
+1,000,719
New +$69.7M 0.46% 61

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Silvercrest Asset Management's CNMD Position: Q2 2026 in Review

Silvercrest Asset Management reduced its CONMED (CNMD) stake by 32% in Q2 2026, selling an estimated $7.46M and leaving 441,361 shares worth $14.4M. The position accounts for 0.09% of the portfolio, ranked #277.

Silvercrest Asset Management first reported a position in CNMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $68.5M in Q4 2024. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Silvercrest Asset Management held 441,361 shares of CONMED worth $14.4M as of Q2 2026.
  • Silvercrest Asset Management sold 207,216 CONMED shares in Q2 2026, an estimated $7.46M.
  • CONMED made up 0.09% of Silvercrest Asset Management's portfolio in Q2 2026, its #277 holding.
  • Silvercrest Asset Management first reported a position in CONMED in Q4 2024 and has held it in 7 quarters since.
  • Silvercrest Asset Management's CONMED position peaked at $68.5M in Q4 2024.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Silvercrest Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.